Breathing without drugs: biofeedback trial aims to ease persistent shortness of breath

NCT ID NCT05973513

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This UCLA study tests whether biofeedback—a technique that teaches control over heart rate, breathing, and body temperature—can relieve shortness of breath in people who haven't gotten better with inhalers or pulmonary rehab. Twenty-five adults aged 18–60 with ongoing respiratory symptoms will attend six sessions. The goal is to see if symptoms, mood, sleep, and quality of life improve.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
biofeedback (heart-rate variability training, relaxation, temperature control)
What this could lead to
If it works, this could offer a non-drug way to manage persistent breathing problems and improve quality of life.
What could go wrong
This is a small, early-stage trial with only 25 people and no comparison group, so results may not apply widely. It also relies on self-reported improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORTNESS OF BREATH/DYSPNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyspnea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Natacha Emerson

    Los Angeles, California, 90095, United States